NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK InhibitionMOLECULAR CANCER THERAPEUTICSIF5.52022-10-057OAAI
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expressionNPJ PRECISION ONCOLOGYIF82022-06-2914OAAI
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic VulnerabilityCANCER RESEARCHIF16.62021-01-1329OA
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities低级别浆液性卵巢癌的基因组分析,以确定关键驱动因素和治疗脆弱性JOURNAL OF PATHOLOGYIF5.22020-10-2869OAAI
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic targetCANCER CELL INTERNATIONALIF62019-01-0829OAAI
MICROFLUIDIC MAINTENANCE OF OVARIAN TUMOUR BIOPSIES FOR THE STUDY OF HYPERCOAGUABILITY DURING CHEMOTHERAPYANNALS OF ONCOLOGYIF65.42014-09-011OAAI